Aloe Vera in Chronic Periodontitis With Type 2 Diabetes Mellitus
Study Details
Study Description
Brief Summary
The present study is designed to investigate the effectiveness of AV gel local drug delivery as an adjunct to scaling and root planing (SRP) in the treatment of subjects with chronic periodontitis (CP) and type 2 diabetes mellitus (DM).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2/Phase 3 |
Detailed Description
BACKGROUND: Advances in the field of alternative medicine have promoted widespread use of herbal agents, like Aloe vera (AV), for both medical and dental therapy. AV has anti-inflammatory, antioxidant, antimicrobial, hypoglycaemic, healing promoting and immune boosting properties. The present study is designed to investigate the effectiveness of AV gel local drug delivery as an adjunct to scaling and root planing (SRP) in the treatment of subjects with chronic periodontitis (CP) and type 2 diabetes mellitus (DM).
MATERIAL AND METHODS: A total of 60 subjects with probing depth (PD) ≥5mm and clinical attachment level (CAL) ≥3mm were randomly divided into two groups. Group 1 was treated with SRP + placebo gel local drug delivery (LDD) and Group 2 with SRP + AV gel LDD. Clinical parameters including full mouth plaque index (PI), modified sulcus bleeding index (mSBI), probing depth (PD) and clinical attachment level (CAL) were recorded first at baseline and then at intervals of 3 months and 6 months.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Placebo Comparator: Placebo After SRP, placebo gel was delivered subgingivally into periodontal pockets. |
Drug: placebo gel
After SRP, placebo gel was delivered subgingivally into periodontal pockets.
|
Active Comparator: Aloe vera After SRP, aloe vera gel was delivered subgingivally into periodontal pockets. |
Drug: aloe vera
After SRP, aloe vera gel was delivered subgingivally into periodontal pockets.
|
Outcome Measures
Primary Outcome Measures
- Change in Clinical attachment level [baseline to 6 months]
Secondary Outcome Measures
- Change in Plaque index [baseline to 6 months]
- Change in modified sulcus bleeding index [baseline to 6 months]
- Change in Probing depth [baseline to 6 months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Well-controlled type 2 DM
-
Chronic periodontitis with moderate to deep pockets [probing depth (PD) ≥5mm and clinical attachment loss (CAL) ≥3mm]
-
No history of antibiotic or periodontal therapy in the preceding 6 months.
Exclusion Criteria:
-
Any known disease/condition or on any medication that can affect the periodontal status
-
Known or suspected allergy to herbal medications
-
Systemic antimicrobial therapy
-
Aggressive periodontitis
-
Smokers
-
Alcoholics
-
Immunocompromised patients
-
Pregnant or lactating females
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Government Dental College and Research Institute, Bangalore
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- GDCRI/ACM/PG/PhD/10E/2013-14